List of SBIR/STTR awards granted to inXsol
inXsolName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to inXsol in March, 2021 for $100,000.0 USD from the U.S. Department of Agriculture. | SBIR | 2021-00640 | Phase I | 100,000 | March 1, 2021 | |||||||
A SBIR Phase II contract was awarded to inXsol in June, 2019 for $199,900.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44ES028145-02A1 | Phase II | 199,900 | June 1, 2019 | |||||||
A SBIR Phase I contract was awarded to inXsol in June, 2017 for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43ES028145-01 | Phase I | 100,000 | June 1, 2017 | |||||||
A SBIR Phase I contract was awarded to inXsol for $99,373.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43ES015697-01 | Phase I | 99,373 | ||||||||
A SBIR Phase I contract was awarded to inXsol for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43ES021640-01 | Phase I | 100,000 | ||||||||
A SBIR Phase II contract was awarded to inXsol for $400,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44ES021640-02 | Phase II | 400,000 | ||||||||
A SBIR Phase I contract was awarded to inXsol for $149,999.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43ES022919-01A1 | Phase I | 149,999 | ||||||||
A SBIR Phase II contract was awarded to inXsol for $396,092.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44ES015697-02 | Phase II | 396,092 | ||||||||
A SBIR Phase I contract was awarded to inXsol for $149,771.0 USD from the National Science Foundation. | SBIR | 0945987 | Phase I | 149,771 | ||||||||
A SBIR Phase I contract was awarded to inXsol in May, 2023 for $100,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43ES035290-01 | Phase I | 100,000 | May 1, 2023 |
